Brief: Latigo Biotherapeutics Announces IPO Of Common Stock
BRIEF-Latigo Biotherapeutics Announces IPO Of Common Stock July 17 (Reuters) - Latigo Biotherapeutics:
LATIGO BIOTHERAPEUTICS - ANNOUNCES INITIAL PUBLIC OFFERING OF COMMON STOCK - SEC FILING
LATIGO BIOTHERAPEUTICS - APPLIES TO LIST ON NASDAQ UNDER SYMBOL LTGO - SEC FILING
LATIGO BIOTHERAPEUTICS: GOLDMAN SACHS & CO. LLC, JEFFERIES, LEERINK PARTNERS, GUGGENHEIM SECURITIES ARE UNDERWRITERS TO IPO
Source text: [ID:n0001193125-26-307306]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Blue Owl Capital
See all newsAlternative asset managers rally after Blackstone earnings
Cable capacity emerges as bottleneck for AI data centres, Nexans says
ROI-Five AI quirks and conundrums to watch this earnings season: McGeever
ROI-Five AI quirks and conundrums to watch this earnings season: McGeever
Sells 900,630 Common Shares For $9.60 Million Based On Sept 30, 2026 Nav Per Share - SEC Filing